Patrick S. Chaftari, MD, MBA, CHCQM-PHYADV, FACP
Department of Emergency Medicine, Division of Internal Medicine
About Dr. Chaftari
Dr. Patrick Chaftari is a provider in the MD Anderson Emergency Center and an Assistant Professor in the Department of Emergency Medicine. He is board-certified in Internal Medicine and joined MD Anderson in 2009.
Education & Training
Degree-Granting Education
| 1992 | Saint Joseph University, Beirut, LBN, MD, Medicine |
Postgraduate Training
| 1997-2000 | Clinical Residency, Internal Medicine, Staten Island University Hospital, Staten Island, NY |
| 1996-1997 | Clinical Internship, Internal Medicine, Staten Island University Hospital, Staten Island, NY |
| 1995-1996 | Clinical Internship, Surgery, Staten Island University Hospital, Staten Island, NY |
| 1993-1995 | Clinical Residency, Orthopedic Surgery, Lebanese University, Beirut |
Board Certifications
| 1999 | Internal Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Department of Emergency Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2018
Assistant Professor, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2010
Selected Publications
Peer-Reviewed Articles
- Chaftari P, Chaftari AM, Adachi J, Hachem R, Raad S, Natividad E, Oliver N, Ellickalputhenpura B, Jiang Y, Tarrand J, Raad I. Improvement in the diagnosis of catheter-related bloodstream infections in a tertiary cancer center. Am J Infect Control 45(3):e34-e39, 2017. PMID: 28254252.
- Gonzalez CE, Cruz-Carreras MT, Guha-Thakurta N, Brydges N, Chaftari P. A Rare Case of Extramedullary Plasmacytoma of the Pleura Causing Spinal Cord Compression in a Patient with Multiple Myeloma. Med Sci Case Rep 2017(4):19-23, 2017. e-Pub 2017.
Abstracts
- Anne-Marie Chaftari, Ray Hachem, Alexandre E Malek, Victor Mulanovich, Ariel Szvalb, Ying Jiang, Shahnoor Ali, Rita Deeba, Patrick Chaftari, Issam Raad. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies. ID Week 2020 Virtual Conference, Online, Oct 21, 2020 (#1257), 10/2020, 2020.